Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges in implementing a successful newborn cystic fibrosis screening program.

Anne Marie Comeau1, Richard Parad, Robert Gerstle

  • 1New England Newborn Screening Program of the University of Massachusetts Medical School, MA 02130, USA. anne.comeau@umassmed.edu

The Journal of Pediatrics
|October 6, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-genome sequencing with AVITI and NovaSeq X Plus reveals comparable performance with contextual biases.

NAR genomics and bioinformatics·2026
Same author

Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis.

American journal of hematology·2026
Same author

Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same author

Evidence Regarding Metachromatic Leukodystrophy Newborn Screening.

Pediatrics·2025
Same author

Evidence Regarding Duchenne Muscular Dystrophy Newborn Screening.

Pediatrics·2025
Same author

Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

Successful cystic fibrosis (CF) newborn screening (NBS) programs require careful planning. Key components include involving CF center directors, choosing appropriate screening algorithms, and addressing logistical, reporting, follow-up, and educational needs.

Area of Science:

  • Public Health
  • Genetics
  • Pediatrics

Background:

  • Newborn screening (NBS) is crucial for early detection of genetic disorders.
  • Cystic Fibrosis (CF) is a significant genetic condition requiring timely diagnosis and intervention.
  • Establishing effective NBS programs for CF presents unique logistical and clinical challenges.

Purpose of the Study:

  • To identify essential components for a successful cystic fibrosis newborn screening program.
  • To provide guidance for states implementing or improving CF NBS.

Main Methods:

  • Examination of the Massachusetts newborn screening program's approach to CF screening.
  • Analysis of key elements contributing to program success.

Main Results:

Related Experiment Videos

  • Inclusion of CF center directors in program development.
  • Careful selection of screening algorithms considering community and practice factors.
  • Projections of medical service needs based on chosen algorithms.
  • Identification of critical reporting and follow-up components.
  • Recognition of essential educational needs for stakeholders.

Conclusions:

  • Optimal implementation of NBS for CF necessitates a thorough examination of various program components.
  • Proactive planning addressing logistical, clinical, and educational aspects is vital for successful CF NBS programs.